Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-26

FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for Mesalamine from Zydus Lifesciences Limited, resulting in updated labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)